These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
587 related articles for article (PubMed ID: 9458078)
1. Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Hyder SM; Murthy L; Stancel GM Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078 [TBL] [Abstract][Full Text] [Related]
2. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells. Liang Y; Wu J; Stancel GM; Hyder SM J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260 [TBL] [Abstract][Full Text] [Related]
3. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. Menendez JA; Oza BP; Colomer R; Lupu R Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749 [TBL] [Abstract][Full Text] [Related]
5. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines. Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells. Hyder SM; Chiappetta C; Stancel GM Int J Cancer; 2001 May; 92(4):469-73. PubMed ID: 11304678 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers. Joseph IB; Isaacs JT Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270 [TBL] [Abstract][Full Text] [Related]
8. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells. Mirkin S; Wong BC; Archer DF Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894 [TBL] [Abstract][Full Text] [Related]
9. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation. Jeng MH; Parker CJ; Jordan VC Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300 [TBL] [Abstract][Full Text] [Related]
10. Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells. Hyder SM; Liang Y; Wu J; Welbern V Endocr Relat Cancer; 2009 Sep; 16(3):809-17. PubMed ID: 19570906 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration. Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489 [TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells. Carroll CE; Ellersieck MR; Hyder SM Menopause; 2008; 15(3):570-4. PubMed ID: 18467956 [TBL] [Abstract][Full Text] [Related]
13. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells. Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614 [TBL] [Abstract][Full Text] [Related]
14. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases. van der Pluijm G; Sijmons B; Vloedgraven H; Deckers M; Papapoulos S; Löwik C J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785 [TBL] [Abstract][Full Text] [Related]
15. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells. Purmonen S; Manninen T; Pennanen P; Ylikomi T Oncol Rep; 2008 Jun; 19(6):1627-34. PubMed ID: 18497975 [TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Yoshiji H; Gomez DE; Shibuya M; Thorgeirsson UP Cancer Res; 1996 May; 56(9):2013-6. PubMed ID: 8616842 [TBL] [Abstract][Full Text] [Related]
17. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis. Yen L; You XL; Al Moustafa AE; Batist G; Hynes NE; Mader S; Meloche S; Alaoui-Jamali MA Oncogene; 2000 Jul; 19(31):3460-9. PubMed ID: 10918604 [TBL] [Abstract][Full Text] [Related]
18. Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma. Balsari A; Maier JA; Colnaghi MI; Ménard S Lab Invest; 1999 Jul; 79(7):897-902. PubMed ID: 10418830 [TBL] [Abstract][Full Text] [Related]
19. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma. Pal S; Datta K; Mukhopadhyay D Cancer Res; 2001 Sep; 61(18):6952-7. PubMed ID: 11559575 [TBL] [Abstract][Full Text] [Related]
20. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis. Seeger H; Wallwiener D; Mueck AO Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]